NCT06915675

Brief Summary

This split-mouth pilot study evaluates the effectiveness of flowable decellularized Human Placental Connective Tissue Matrix (HPCTM) in alveolar ridge preservation following tooth extraction. Patients will receive HPCTM mixed with allograft particles in one extraction socket and allograft particles solely in the contralateral socket. The primary outcome is to assess dimensional changes in the alveolar ridge in terms of soft tissue shrinkage using a super-imposed intra-oral scans taken at baseline , day 10, 21 and 30 post-op and bone resorption rate by comparing pre-op and 4 months post-op cone beam computed tomography scans. Secondary outcomes include clinical soft tissue healing evaluation and commentary. The HPCTM used in this study is regulated by the US FDA under Section 361 of the Public Health Service Act (21 CFR Part 1271.10(a)).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 23, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 8, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

March 28, 2025

Last Update Submit

April 8, 2025

Conditions

Keywords

Alveolar ridgeConnective tissueExtracellular matrixPlacental extractsWound healingTooth extraction

Outcome Measures

Primary Outcomes (2)

  • Soft tisse shrinakge at different time points of the test and control groups

    Using a measurement software ( Medit design, Medit, Republic of Korea) the intra-oral scans (.STL files) obtained at different time points of the healing process will be super-imposed and aligned. the following region of interest will be selected: * Mesio-distally: 1,5 mm away from the concerned papilla peak. * Apically: A bucco-lingual/palatal line tangent to the visible muco-gingival line and parallel to the occlusal surface. The deviation between the different scans which corresponds the soft tissue shrinkage will be automatically calculated in millimeters as a mean value with standard deviation

    30 days

  • Bone resorption rate in test and control groups

    . A semi-automatic segmentation software (ITK-Snap 4.0, U.S. National Institute of Biomedical Imaging and BioEngineering, USA) was used to load and segment the pre and post CBCT scans. First, both CBCTs were oriented according to the Frankfort plane, then aligned using multiple fixe landmarks in different orientations to ensure a perfect match and an easy reproducibility. A standard region of interest was applied for all the measured sites as follow: A standard region of interest was applied for all the measured sites as follow: * Mesio-distal limit: 1.5 mm away from the mesial and distal surface of adjacent tooth. * Bucco-lingual limit: limited to the observed bone dimensions. * Apico-coronal limit: Coronally the most detectable bone peak at the mesial and distal sides; apically, 1.5 mm below the root tip. Using pixel-based scale, a specific threshold value was used to select and separate the desired structure from its surroundings of both pre and post-surgery CBCT. Following the aut

    4 months

Secondary Outcomes (1)

  • Clinical observation of the wound healing at control and test groups at 10, 21 and 30 days post-op

    30 days

Study Arms (2)

Placenta treatment arm

ACTIVE COMPARATOR

Participants will receive allografts bone substitutes mixed with flowable human placental based connective tissue matrix in one extraction socket immediately following tooth extraction.

Biological: Placental Extract

Control arm

SHAM COMPARATOR

Participants will receive allografts bone substitutes solely in one extraction socket immediately following tooth extraction.

Procedure: Allograft

Interventions

Participants will receive allografts bone substitutes mixed with flowable human placental derived connective tissue matrix in one extraction socket immediately following tooth extraction.

Placenta treatment arm
AllograftPROCEDURE

Participants will receive allografts bone substitutes solely in one extraction socket immediately following tooth extraction.

Control arm

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age ranging between 20 and 60.
  • Subjects having two hopeless teeth that needs extraction.
  • Teeth fitting in the same morphological category (mono,bi or multirooted).
  • Teeth belonging to different arch quadrants.
  • Presence of more than half of the socket bone housing.
  • Non-smoking patient.

You may not qualify if:

  • Presence of active periodontal diseases i.e Miller class II and above categories.
  • Presence of heavy metallic artefacts that can distort CBCT scans.
  • Bad oral hygiene and non-compliance.
  • Systemic diseases interfering with bone metabolism.
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Joseph University of Beirut

Beirut, Beyrouth, 1101, Lebanon

Location

Related Publications (4)

  • Gulameabasse S, Gindraux F, Catros S, Fricain JC, Fenelon M. Chorion and amnion/chorion membranes in oral and periodontal surgery: A systematic review. J Biomed Mater Res B Appl Biomater. 2021 Aug;109(8):1216-1229. doi: 10.1002/jbm.b.34783. Epub 2020 Dec 22.

    PMID: 33354857BACKGROUND
  • Kalsi AS, Kalsi JS, Bassi S. Alveolar ridge preservation: why, when and how. Br Dent J. 2019 Aug;227(4):264-274. doi: 10.1038/s41415-019-0647-2.

    PMID: 31444438BACKGROUND
  • Chappuis V, Araujo MG, Buser D. Clinical relevance of dimensional bone and soft tissue alterations post-extraction in esthetic sites. Periodontol 2000. 2017 Feb;73(1):73-83. doi: 10.1111/prd.12167.

    PMID: 28000281BACKGROUND
  • Chappuis V, Engel O, Reyes M, Shahim K, Nolte LP, Buser D. Ridge alterations post-extraction in the esthetic zone: a 3D analysis with CBCT. J Dent Res. 2013 Dec;92(12 Suppl):195S-201S. doi: 10.1177/0022034513506713. Epub 2013 Oct 24.

    PMID: 24158340BACKGROUND

Related Links

MeSH Terms

Interventions

Placental ExtractsTransplantation, Homologous

Intervention Hierarchy (Ancestors)

Tissue ExtractsComplex MixturesTransplantationSurgical Procedures, Operative

Study Officials

  • Ronald Joseph Younes, DDS,MSc, Phd

    Saint Joseph University of Beirut

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Following the inclusion and exclusion criteria, 10 patients presenting a split mouth design will be enrolled in the study where one dental extraction site will serve as a test and the other will be the control
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 8, 2025

Study Start

August 23, 2024

Primary Completion

February 11, 2025

Study Completion

April 10, 2025

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations